Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 131538, 7 pages
http://dx.doi.org/10.1155/2014/131538
Clinical Study

Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes

1Department of Ophthalmology, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, Poland
2Department of Anesthesiology and Intensive Care Medicine, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, Poland

Received 16 August 2013; Revised 28 November 2013; Accepted 24 December 2013; Published 10 February 2014

Academic Editor: Katarzyna Zorena

Copyright © 2014 Anna Gębka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Haskins, B. Bradley, K. Powers et al., “Oxidative stress in type 1 diabetes,” Annals of the New York Academy of Sciences, vol. 1005, pp. 43–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Adamis, “Is diabetic retinopathy an inflammatory disease?” British Journal of Ophthalmology, vol. 86, no. 4, pp. 363–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Shamoon, H. Duffy, N. Fleischer et al., “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Du, T. Matsumura, D. Edelstein et al., “Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells,” The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1049–1057, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Zong, M. Ward, and A. W. Stitt, “AGEs, RAGE, and diabetic retinopathy,” Current Diabetes Reports, vol. 11, no. 4, pp. 244–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kaul, A. Hodgkinson, J. M. Tarr, E. M. Kohner, and R. Chibber, “Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?” Current Diabetes Reviews, vol. 6, no. 5, pp. 294–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kaštelan, M. Tomić, A. Gverović Antunica, J. S. Rabatić, and S. Ljubić, “Inflammation and pharmacological treatment in diabetic retinopathy,” Mediators of Inflammation, vol. 2013, Article ID 213130, 8 pages, 2013. View at Publisher · View at Google Scholar
  11. Y. Du, A. Veenstra, K. Palczewski, and T. S. Kern, “Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 41, pp. 16586–16591, 2013. View at Publisher · View at Google Scholar
  12. X.-L. Zhang, L. Wen, Y.-J. Chen, and Y. Zhu, “Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide,” Chinese Medical Journal, vol. 122, no. 3, pp. 338–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Georgakopoulos, M. I. Eliopoulou, A. M. Exarchou, V. Tzimis, N. M. Pharmakakis, and B. E. Spiliotis, “Decreased contrast sensitivity in children and adolescents with type 1 diabetes mellitus,” Journal of Pediatric Ophthalmology and Strabismus, vol. 48, no. 2, pp. 92–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Krasny, M. Andel, R. Brunnerova et al., “The contrast sensitivity test in early detection of ocular changes in the relation to the type I diabetes mellitus compensation in children, teenagers, and young adults,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 1, no. 3, pp. 232–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Y. Sukha and A. Rubin, “High, medium, and low contrast visual acuities in diabetic retinal disease,” Optometry & Vision Science, vol. 86, no. 9, pp. 1086–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Gualtieri, M. Bandeira, R. D. Hamer, F. M. Damico, A. L. A. Moura, and D. F. Ventura, “Contrast sensitivity mediated by inferred magno- and parvocellular pathways in type 2 diabetics with and without nonproliferative retinopathy,” Investigative Ophthalmology & Visual Science, vol. 52, no. 2, pp. 1151–1155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. K. Hegazy, O. A. Tolba, T. M. Mostafa, M. A. Eid, and D. R. El-Afify, “Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes,” The Review of Diabetic Studies, vol. 10, no. 1, pp. 58–67, 2013. View at Publisher · View at Google Scholar
  18. A. Udupa, P. Nahar, S. Shah, M. Kshirsagar, and B. Ghongane, “A comparative study of effects of omega-3 fatty acids, alpha lipoic Acid and vitamin e in type 2 diabetes mellitus,” Annals of Medical and Health Sciences Research, vol. 3, no. 3, pp. 442–446, 2013. View at Publisher · View at Google Scholar
  19. X. Du, D. Edelstein, and M. Brownlee, “Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes,” Diabetologia, vol. 51, no. 10, pp. 1930–1932, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Lin, A. Bierhaus, P. Bugert et al., “Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy,” Diabetologia, vol. 49, no. 5, pp. 1089–1096, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bucolo, G. Marrazzo, C. B. M. Platania, F. Drago, G. M. Leggio, and S. Salomone, “Fortified extract of red berry, gingko biloba, and white willow bark in experimental early diabetic retinopathy,” Journal of Diabetes Research, vol. 2013, Article ID 432695, 6 pages, 2013. View at Publisher · View at Google Scholar
  22. L. J. Reed, “A trail of research from lipoic acid to α-keto acid dehydrogenase complexes,” The Journal of Biological Chemistry, vol. 276, no. 42, pp. 38329–38336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-P. Carreau, “Biosynthesis of lipoic acid via unsaturated fatty acids,” Methods in Enzymology, vol. 62, pp. 152–158, 1979. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. Biewenga, G. R. M. M. Haenen, and A. Bast, “The pharmacology of the antioxidant: lipoic acid,” General Pharmacology, vol. 29, no. 3, pp. 315–331, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Randle, “Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years,” Diabetes/Metabolism Reviews, vol. 14, no. 4, pp. 263–283, 1998. View at Publisher · View at Google Scholar
  26. L. Packer, E. H. Witt, and H. J. Tritschler, “Alpha-lipoic acid as a biological antioxidant,” Free Radical Biology & Medicine, vol. 19, no. 2, pp. 227–250, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Jones, X. Li, Z.-C. Qu, L. Perriott, R. R. Whitesell, and J. M. May, “Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells,” Free Radical Biology & Medicine, vol. 33, no. 1, pp. 83–93, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. Position of the Polish Diabetes Association, “Clinical recommendations for treatment of patients with diabetes,” Journal of the Diabetes Poland, vol. 12, supplement A, pp. 3–7, 2011. View at Google Scholar
  29. American Diabetes Association, “Diagnosis and classification of diabetes,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010. View at Publisher · View at Google Scholar
  30. R. A. Kowluru and S. Odenbach, “Effect of long-term administration of α-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats,” Diabetes, vol. 53, no. 12, pp. 3233–3238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Porasuphatana, S. Suddee, A. Nartnampong, J. Konsil, B. Harnwong, and A. Santaweesuk, “Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study,” Asia Pacific Journal of Clinical Nutrition, vol. 21, no. 1, pp. 12–21, 2012. View at Google Scholar · View at Scopus
  32. A. S. Udupa, P. S. Nahar, S. H. Shah, M. J. Kshirsagar, and B. B. Ghongane, “Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus,” Journal of Clinical and Diagnostic Research, vol. 6, no. 9, pp. 1469–1473, 2012. View at Publisher · View at Google Scholar